|
|
Article: FDA Approves New Product With Two Medicines For Helping To Prevent Heart Attacks In People With Heart Disease; Convenient New Option to Help Prevent a Heart Attack in People with Heart Disease; Both Statins and Aspirin Recommended by American College of Cardiology and American Heart Association Guidelines.
- Article from:
- PR Newswire
- Article date:
- June 25, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, June 25 /PRNewswire/ -- BACKGROUND: This year over a half million Americans will suffer a heart attack. These patients are at an increased risk of having another event or dying within the year. Many of these patients have to make significant lifestyle changes including diet, exercise and taking medications to reduce their risk. But the Food and Drug Administration has now approved a new product that may help. The FDA has approved PRAVIGARD PAC, which co-packages two widely used medications -- Pravachol and aspirin -- side-by-side in a single convenient package. For people with heart disease for whom treatment with both Pravachol and Buffered Aspirin is ...
Related newspaper, magazine, and journal articles:
|
|
Article: WASHINGTON AGENDA-FEDERAL
United Press International;
July 17, 2002 ;
700+ words
... ... the committee will discuss new drug application 21-387, PRAVIGARD PAC, Bristol-Myers Squibb Co., proposed for long- term ... ischemic stroke) in patients with clinically evident coronary heart disease. DATE: July 18, 2002 LOCATION: Holiday Inn, Versailles ...
|
|